NCT05718128 Clinical Study of Endocardial Myocardial Biopsy
| NCT ID | NCT05718128 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Myocarditis |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2021-06-01 |
| Primary Completion | 2031-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 100 participants in total. It began in 2021-06-01 with a primary completion date of 2031-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.
Eligibility Criteria
Inclusion Criteria: * Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine; * Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause; * Have the ability to understand the test, can cooperate with investigators. Exclusion Criteria: * Unable to understand or unwilling to fill in informed consent forms or follow visitors.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05718128 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Myocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT05718128 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT05718128 currently recruiting?
Yes, NCT05718128 is actively recruiting participants. Contact the research team at heartpanxh@163.com for enrollment information.
Where is the NCT05718128 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT05718128 clinical trial?
NCT05718128 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 100 participants.